Services we offer

Home » Products and Services

Innovative Medical And Therapeutic Products

Wound Closure - Regenerative Medicine

Interfyl Connective Tissue Matrix CTM

Available in Flowable and Particulate form to meet a variety of surgical application needs in sizes up to 275mg
Can be used with acute injuries and/or chronic conditions
Structural Allograft
Intended for Homologous Use (does not contain amnion)
Ready to use with room temperature storage
All products are FDA approved/TRG 361
Acellular Placental Extracellular Matrix Allograft (ECM). Non-Amniotic.
Naturally occurring ECMs are comprised of fibrous proteins that provide structural support for tissue regeneration.
ECMs contain highly regenerative growth factors to assist in modulating inflammation, tissue formation and tissue remodeling.
Interfyl is a tissue allograft produced from healthy human donors intended for homologous use to supplement or replace damaged or inadequate connective tissue.
Interfyl is a 361 HCT/P because it is a structural human tissue allograft. It is comprised of extracellular matrix (ECM) derived from non-amnion placental tissue. It is intended to serve as a scaffold that provides physical support and cushioning of the tissue. While serving as conduit that connects and supports cellular activity.
10 year shelf life
Contains only key component of connective tissue matrix

Amniotic Membrane is an amniotic membrane made from placental tissue.
Placental tissues are known to contain collagen substrates, growth factors and extracellular matrix proteins recognized as part of the complex wound healing process.
Minimally processed to preserve the structure and contents of the native tissues including growth factors, hyaluronic acid, interleukins and other cytokines.
Intended for homologous use to supplement a recipient's tissue while providing a wound covering and support for native tissue.

Applications may include:

Features:

Easily cut and shaped
Varies sizes available
No specific orientation required
Resorbable barrier
Sterile
Room temp storage (15 degrees C TO 30 degrees C)
5 year shelf life

What We Offer

Practice Consulting Solutions

Support We Offer

Implementation of In-Office Wound Care Program
IVR Support (Insurance Verification)
Wound Care Marketing Support
Graft Application Support
Peer to Peer Support
Ordering/Shipping support
Graft Membrane Billing Support
Reimbursement Support

Offering integration consulting to medical practices requires a tailored approach, we consider their unique needs and challenges. By providing tailored support and ongoing assistance, these practices can improve their quality of care and achieve long-term sustainability.

We assess the specific needs and challenges of the practices with a key focus on minority owned medical practices:

It is important to understand the specific needs and challenges of minority medical practices.
Through interviews, surveys, and data analysis we identify areas that need improvement and opportunities for growth.

Develop a tailored integration strategy.

Based on the assessment of the minority medical practices, a tailored integration strategy will be developed to address their specific needs and challenges.
The integration strategy is designed to support the practices in providing high-quality, patient-centered care and to ensure their long-term sustainability.

We provide support for implementing the integration strategy:

Providing ongoing support to ensure the successful adoption of the integration strategy.

Our Mission

Our mission is to provide high-quality healthcare solutions, therapies and consulting services to individuals and communities, with a focus on promoting wellness, preventing illness, and treating disease. We strive to continuously improve our services and technologies, and to work collaboratively with patients, families, caregivers, and other stakeholders to deliver personalized and patient-centered care that meets their needs and preferences. We are committed to fostering a culture of respect, diversity, equity, and inclusion, and to upholding ethical and professional standards in all aspects of our operations. Ultimately, our goal is to contribute to the well-being and flourishing of society, and to support individuals in achieving their full potential for health and vitality.

Clinical Information

Biologics Publication References

1. Kjaergaard N et al. Antibacterial Properties of Human Amnion and Chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2000; 94:224-229.

2. Talmi YP et al. Antibacterial Properties of Human Amniotic Membranes. Placenta. 1991; 12:285-288.

3. Fairbairn et al, The clinical applications of human amnion in plastic surgery. J Plast Reconstr Aesthet Surg. 2014. Jan 31. pii:S1748-6815(14)00037-0.

4. Kesting MR et al. The Role of Allogenic Amniotic Membrane in Burn Treatment. J Burn Care Res. 2008;29:907-916

5. Garten A. A closer look at amniotic membrane allografts for wounds. Podiatry Today. Epub 11/12/14.

6. Park C, Y, Kohanim S, Zhu L, Gehlbach P, L, Chuck R, S: Immunosuppressive Property of Dried Human Amniotic Membrane. Ophthalmic Res 2009;41:112-113. doi: 10.1159/000187629

7. The presence of extracellular matrix was confirmed by internal measurements of collagen (Sirius Red, Chondrex) and hyaluronic acid (Hyaluronan Quantkine ELISA Kit, R&D Systems).

8. The presence of growth factors confirmed by third party testing using fluorescent multiplex ELISA (Quantbody® Human Growth Factor Array, Ray BioTech).

Email

Phone